Jefferies Financial Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Jefferies Financial Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$339M	Sell	2,140,001 -174,719	-8%	-$23.6M	2.23%	5
2026 Q1	$296M	Buy	2,314,720 +599,631	+35%	+$74.9M	2.02%	5
2025 Q4	$209M	Buy	1,715,089 +209,019	+14%	+$24M	1.07%	13
2025 Q3	$151M	Buy	1,506,070 +74,191	+5%	+$6.68M	0.71%	20
2025 Q2	$119M	Buy	1,431,879 +636,869	+80%	+$50.8M	1%	9
2025 Q1	$64.5M	Buy	795,010 +184,277	+30%	+$16.5M	0.57%	24
2024 Q4	$55M	Buy	610,733 +541,290	+779%	+$52.4M	0.33%	57
2024 Q3	$6.86M	Buy	69,443 +21,512	+45%	+$2.11M	0.05%	248
2024 Q2	$4.44M	Sell	47,931 -760,730	-94%	-$68.2M	0.05%	333
2024 Q1	$76.7M	Buy	808,661 +612,688	+313%	+$56.9M	0.71%	20
2023 Q4	$17.5M	Sell	195,973 -811,816	-81%	-$60.3M	0.11%	122
2023 Q3	$73.6M	Buy	1,007,789 +5,415	+0.5%	+$433K	0.66%	21
2023 Q2	$83.4M	Sell	1,002,374 -25,036	-2%	-$2.09M	0.75%	23
2023 Q1	$78.3M	Buy	1,027,410 +282,193	+38%	+$23.4M	0.63%	19
2022 Q4	$61.9M	Buy	+745,217	New	+$60.3M	0.43%	34

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jefferies Financial Group's XBI Position: Q2 2026 in Review

Jefferies Financial Group reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 7.5% in Q2 2026, selling an estimated $23.6M and leaving 2,140,001 shares worth $339M. The position accounts for 2.23% of the portfolio, ranked #5.

Jefferies Financial Group first reported a position in XBI in Q4 2022 and has held it in 15 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Jefferies Financial Group held 2,140,001 shares of State Street SPDR S&P Biotech ETF worth $339M as of Q2 2026.
Jefferies Financial Group sold 174,719 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $23.6M.
State Street SPDR S&P Biotech ETF made up 2.23% of Jefferies Financial Group's portfolio in Q2 2026, its #5 holding.
Jefferies Financial Group first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and has held it in 15 quarters since.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.